A pilot of the feasibility and usefulness of an aged obese model for use in stroke research.

Wellcome Open Research
Annastazia E LearoydRebecca C Trueman

Abstract

Background: Animal models of stroke have been criticised as having poor predictive validity, lacking risk factors prevalent in an aging population. This pilot study examined the development of comorbidities in a combined aged and high-fat diet model, and then examined the feasibility of modelling stroke in such rats. Methods: Twelve-month old male Wistar-Han rats (n=15) were fed a 60% fat diet for 8 months during which monthly serial blood samples were taken to assess the development of metabolic syndrome and pro-inflammatory markers. Following this, to pilot the suitability of these rats for undergoing surgical models of stroke, they underwent 30min of middle cerebral artery occlusion (MCAO) alongside younger controls fed a standard diet (n=10). Survival, weight and functional outcome were monitored, and blood vessels and tissues collected for analysis. Results: A high fat diet in aged rats led to substantial obesity. These rats did not develop type 2 diabetes or hypertension. There was thickening of the thoracic arterial wall and vacuole formation in the liver; but of the cytokines examined changes were not seen. MCAO surgery and behavioural assessment was possible in this model (with some caveats discussed in manuscript). Co...Continue Reading

References

Nov 1, 1992·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Jan 1, 1989·Stroke; a Journal of Cerebral Circulation·E Z LongaR Cummins
Aug 1, 1997·The American Journal of Physiology·B E LevinR E Keesey
Dec 3, 1999·Stroke; a Journal of Cerebral Circulation·UNKNOWN Stroke Therapy Academic Industry Roundtable (STAIR)
Nov 3, 2001·Stroke; a Journal of Cerebral Circulation·A J GrauH C Diener
Jul 5, 2003·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·I BadanA Popa-Wagner
Dec 18, 2003·The Journal of Clinical Investigation·Haiyan XuHong Chen
Jun 24, 2004·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M MaachiJ-P Bastard
Mar 10, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ulrich Dirnagl
Mar 15, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C-S KimR Yu
May 25, 2006·Journal of Molecular Endocrinology·R BuettnerL C Bollheimer
Apr 12, 2007·Obesity·Roland BuettnerL Cornelius Bollheimer
Aug 19, 2007·Current Neurovascular Research·Aurel Popa-WagnerLary C Walker
Feb 28, 2009·Stroke; a Journal of Cerebral Circulation·Marc FisherUNKNOWN STAIR Group
Apr 20, 2010·Neurochemistry International·Ting ZhangFeng-Yan Sun
Oct 27, 2011·PloS One·Matthias W SieberChristiane Frahm
Mar 8, 2013·Laboratory Animals·S StöppelerR Bahde
Aug 5, 2015·Journal of Neuroinflammation·Samaneh MaysamiCatherine B Lawrence
Nov 26, 2015·Life Sciences·Sulagna Dutta, Pallav Sengupta
Jun 19, 2016·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Rebecca C TruemanStephen B Dunnett
Apr 1, 2017·The Journal of Endocrinology·Greg M KowalskiClinton R Bruce

❮ Previous
Next ❯

Software Mentioned

SPSS
Figshare
GraphPad Prism
ImageJ
R

Related Concepts

Related Feeds

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.